RRGB Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now for an impatient trader. RRGB is in a clear downtrend (bearish MA stack and worsening MACD), sitting right on key support (~3.755) with elevated risk of a breakdown. Options positioning is call-heavy (bullish sentiment), and there’s a supportive analyst upgrade, but there’s no near-term catalyst, no proprietary buy signals today, and the latest quarter showed negative revenue/EPS trends. Net: avoid new buys here; better to sell/step aside until trend and momentum turn up.
Trend/momentum: Bearish. Moving averages are stacked negatively (SMA_200 > SMA_20 > SMA_5), indicating a sustained downtrend. MACD: Histogram -0.0304 and negatively expanding -> bearish momentum is increasing. RSI(6): 22.90 -> deeply oversold/washed-out, which can produce short bounces, but oversold alone is not a reliable buy signal when trend is down. Levels: Pivot 3.992. Immediate support S1 3.755 (price ~3.75 is essentially on it); next support S2 3.609. Resistance levels: R1 4.229, R2 4.375. A bounce would need to reclaim ~3.99–4.23 to improve the setup. Pattern/odds: Similar-pattern stats imply ~50% chance of -0.48% next day, -2.49% next week, +1.49% next month—near-term skew still negative.
Intellectia Proprietary Trading Signals
to Buy from Hold with price target raised to $7 (from $6), framing RRGB as a value pick heading into
Oversold RSI can trigger a reflex bounce if support holds.
Latest quarter showed contracting revenue and worsening EPS (continued fundamental pressure).
Latest reported quarter: 2025/Q3. Revenue: $265.13M, down -3.46% YoY (top-line contraction). Net income: -$18.42M (loss), down -2.42% YoY (still unprofitable). EPS: -1.03, down -14.17% YoY (earnings trend deteriorated). Gross margin: 14.96%, up +10.90% YoY (a bright spot), but not yet translating into profitability. Overall: Mixed-to-negative—margin improvement is encouraging, but declining revenue and deeper EPS losses weaken the near-term investment case.
Recent analyst action: Jefferies upgraded RRGB to Buy from Hold on 2025-12-15 and raised the price target to $7 (from $6), citing compelling risk/reward and value appeal into 2026. Wall Street pro view (pros): Potential value rebound if operations stabilize; margin improvement supports the thesis; upside to PT is large versus $3.75. Wall Street con view (cons): Current tape is bearish; fundamentals show revenue decline and continued losses; without near-term catalysts the stock can stay depressed despite valuation arguments.
